IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 02/22/24
iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 02/22/24
Kirby McInerney LLP Reminds iRhythm Technologies, Inc. (IRTC) Investors of Class Action Filing and Encourages Investors to Contact the FirmBusiness Wire • 02/21/24
IRHYTHM SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their OptionsPRNewsWire • 02/21/24
IRTC SHAREHOLDERS: Shareholders with Significant Losses Should Contact Robbins LLP For Information About Their Rights and RemediesBusiness Wire • 02/20/24
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC)Business Wire • 02/15/24
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC)Business Wire • 02/14/24
IRTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!PRNewsWire • 02/14/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc. (IRTC) InvestorsBusiness Wire • 02/13/24
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in iRhythm Technologies, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 02/13/24
iRhythm Technologies, Inc. (IRTC) Stockholder Notice: Robbins LLP Reminds Investors of iRhythm Technologies, Inc. Class ActionBusiness Wire • 02/13/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc. (IRTC) InvestorsBusiness Wire • 02/12/24
IRTC INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 02/12/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of iRhythm Technologies, Inc. (IRTC) on Behalf of InvestorsBusiness Wire • 02/09/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of iRhythm Technologies, Inc. (IRTC) on Behalf of InvestorsBusiness Wire • 02/08/24
iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024GlobeNewsWire • 02/08/24
The Law Offices of Frank R. Cruz Announces Investigation of iRhythm Technologies, Inc. (IRTC) on Behalf of InvestorsBusiness Wire • 02/08/24
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages iRhythm Technologies, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IRTCPRNewsWire • 02/08/24
IRHYTHM SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTCBusiness Wire • 02/07/24
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc. (IRTC) InvestorsBusiness Wire • 02/07/24
IRTC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead the iRhythm Class Action LawsuitBusiness Wire • 02/07/24
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IRTCBusiness Wire • 02/07/24
Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against iRhythm Technologies, Inc.Business Wire • 02/07/24
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/08/24
